Kaio Pini Santos

Dr. Kaio Pini Santos

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Carbohydrate Polymers
Verified
Journal Article
Closed access
LFLeonardo Miziara Barboza Ferreira
Leonardo Miziara Barboza Ferreira
ASAline M. dos Santos
Aline M. dos Santos
FBFernanda Isadora Boni
Fernanda Isadora Boni
KSKaio Pini Santos
Kaio Pini Santos
LRLeda M. Gorla Robusti
Leda M. Gorla Robusti
MGMaria Palmira Daflon Gremiao
Maria Palmira Daflon Gremiao

27 May 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
BRBruno Vincenzo Fiod Riccio
Bruno Vincenzo Fiod Riccio
ANAndré Luiz Carneiro Soares do Nascimento
André Luiz Carneiro Soares do Nascimento
AMAndréia Bagliotti Meneguin
Andréia Bagliotti Meneguin
CRCamila Fernanda Rodero
Camila Fernanda Rodero
KSKaio Pini Santos
Kaio Pini Santos
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
Trans-resveratrol can promote various dermatological effects. However, its high crystallinity decreases its solubility and bioavailability. Therefore, solid dispersions have been developed to promote its amorphization; even so, they present as powders, making cutaneous controlled drug delivery unfeasible and an alternative necessary for their incorporation into other systems. Thus, polyvinylpyrrolidone (PVP) films were chosen with the aim of developing a controlled delivery system to treat inflammation and bacterial infections associated with atopic dermatitis. Four formulations were developed: two with solid dispersions (and trans-resveratrol) and two as controls. The films presented with uniformity, as well as bioadhesive and good barrier properties. X-ray diffraction showed that trans-resveratrol did not recrystallize. Fourier-transform infrared spectroscopy (FT-IR) and thermal analysis evidenced good chemical compatibilities. The in vitro release assay showed release values from 82.27 ± 2.60 to 92.81 ± 2.50% (being a prolonged release). In the in vitro retention assay, trans-resveratrol was retained in the skin, over 24 h, from 42.88 to 53.28%. They also had low cytotoxicity over fibroblasts. The in vivo assay showed a reduction in inflammation up to 66%. The films also avoided Staphylococcus aureus’s growth, which worsens atopic dermatitis. According to the results, the developed system is suitable for drug delivery and capable of simultaneously treating inflammation and infections related to atopic dermatitis.

12 June 2024 in Journal of Colloid and Interface Science
Verified
Journal Article
Open access
FVFrancesca Damiani Victorelli
Francesca Damiani Victorelli
VLViviane Lutz-Bueno
Viviane Lutz-Bueno
KSKaio Pini Santos
Kaio Pini Santos
DWDi Wu
Di Wu
SSShana Sturla
Shana Sturla
RMRaffaele Mezzenga
Raffaele Mezzenga
Breast cancers that overexpress human epidermal growth factor receptor 2 (HER2) have poor prognosis. Moreover, available chemotherapies cause numerous side effects due to poor selectivity. To advance more effective and safer therapies for HER2-positive breast cancer, we explored the fusion of drug delivery technology and immunotherapy. Our research led to the design of immunocubosomes loaded with panobinostat and functionalized with trastuzumab antibodies, enabling precise targeting of breast cancer cells that overexpress HER2. We characterised the nanostructure of cubosomes using small-angle X-ray scattering (SAXS), cryo-transmission electron microscopy (cryo-TEM), and dynamic light scattering (DLS). Moreover, we confirmed the integrity of the trastuzumab antibodies on the immunocubosomes by Fourier-transform infrared spectroscopy (FTIR) and sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Additionally, we found that panobinostat-loaded immunocubosomes were more cytotoxic, and in an uptake-dependant manner, towards a HER2-positive breast cancer cell line (SKBR3) compared to a cell line representing healthy cells (L929). These results support that the functionalization of cubosomes with antibodies enhances both the effectiveness of the loaded drug and its selectivity for targeting HER2-positive breast cancer cells.

2 November 2020 in Critical Reviews in Analytical Chemistry
Verified
Journal Article
Closed access
KSKaio Pini Santos
Kaio Pini Santos
LRLeidiana Rocha dos Reis
Leidiana Rocha dos Reis
CRCamila Fernanda Rodero
Camila Fernanda Rodero
RSRafael Miguel Sábio
Rafael Miguel Sábio
Alberto Tavares JuniorAlberto Tavares Junior
Alberto Tavares Junior
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
The drug rapamycin is a potent inhibitor of the mTOR complex, acting directly in the signaling cascade of this protein complex; interrupting cell proliferation, in addition to being an extremely efficient immunosuppressant. Currently this drug is being used in several types of cancer. Rapamycin has been a target of great interest within nanomedicine involving nanostructured systems for drug delivery aiming to increase the bioactivity and bioavailability of this drug. In addition, there is a constant search for analytical methods to identify and quantify this drug. Numerous high-performance liquid chromatography analytical techniques, mass spectrometry and immunoassay techniques have been employed efficiently in an attempt to develop increasingly sensitive analytical methods. Thus, this review sought to bring together current and relevant scientific works involving rapamycin and; besides analytical methods more used for quantification of this molecule.

28 July 2022 in Life
Verified
Journal Article
Open access
PDF file
KSKaio Pini Santos
Kaio Pini Santos
CRCamila Fernanda Rodero
Camila Fernanda Rodero
CRCamila Ribeiro
Camila Ribeiro
MGMaria Palmira Daflon Gremiao
Maria Palmira Daflon Gremiao
RPRosângela Gonçalves Peccinini
Rosângela Gonçalves Peccinini
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
Since 1966, rifampicin (RIF) has been considered one of the most potent drugs in the treatment of tuberculosis (TB), which is caused by infection with M. tuberculosis (Mtb). New nanostructured formulations for RIF delivery and alternative routes of administration have been studied as potential forms of treatment. This study evaluates a liquid crystal system for RIF delivery, using alternative drug delivery routes. The systems developed are composed of surfactant, oleylamine, and soy phosphatidylcholine. With the aid of polarized light microscopy, it was possible to determine that the developed systems had a hexagonal mesophase. All systems developed showed non-Newtonian pseudoplasticity and a high degree of thixotropy. Liquid crystal systems with RIF showed an increase in elastic potential, indicating greater mu-coadhesiveness. The evaluation of mucoadhesive forces revealed an increase in the mucoadhesive potential in the presence of mucus, indicating the presence of satisfactory mucoadhesive forces. The 9DR and 10DR liquid crystal systems, when submitted to Differential Scanning Calorimetry analysis, remained structured even at temperatures above 100 °C, showing excellent stability. The developed liquid crystal systems showed a tolerable degree of cytotoxicity and bactericidal potential, for example, the 9DR system demonstrated a reduction in bacterial load after the third day and reached zero CFU on the seventh day of the test. The developed systems were also evaluated in the preclinical model of Mtb-infected mice, using the nasal, sublingual, and cutaneous route for the delivery of RIF associated with a nanostructured liquid crystal system as a possible tool in the treatment of TB.

22 November 2023 in Critical Reviews in Analytical Chemistry
Verified
Journal Article
Closed access
KSKaio Pini Santos
Kaio Pini Santos
LRLeidiana Rocha dos Reis
Leidiana Rocha dos Reis
CRCamila Fernanda Rodero
Camila Fernanda Rodero
RSRafael Miguel Sábio
Rafael Miguel Sábio
Alberto Tavares JuniorAlberto Tavares Junior
Alberto Tavares Junior
Marlus ChorilliMarlus Chorilli
Marlus Chorilli
The drug rapamycin is a potent inhibitor of the mTOR complex, acting directly in the signaling cascade of this protein complex; interrupting cell proliferation, in addition to being an extremely efficient immunosuppressant. Currently this drug is being used in several types of cancer. Rapamycin has been a target of great interest within nanomedicine involving nanostructured systems for drug delivery aiming to increase the bioactivity and bioavailability of this drug. In addition, there is a constant search for analytical methods to identify and quantify this drug. Numerous high-performance liquid chromatography analytical techniques, mass spectrometry and immunoassay techniques have been employed efficiently in an attempt to develop increasingly sensitive analytical methods. Thus, this review sought to bring together current and relevant scientific works involving rapamycin and; besides analytical methods more used for quantification of this molecule.